ANTHEM — Anthem BioSciences Share Price
Last trade - 00:00- IN₹414.69bn
- IN₹408.49bn
- IN₹18.45bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 17.21 | ||
| Price to Tang. Book | 17.24 | ||
| Price to Free Cashflow | 399.48 | ||
| Price to Sales | 22.48 | ||
| EV to EBITDA | 60.85 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 23.45% | ||
| Return on Equity | 20.82% | ||
| Operating Margin | 31.55% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 11,032.4 | 12,312.56 | 10,569.24 | 14,193.7 | 18,445.53 | n/a | n/a | 13.71% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +49.45 | -16.85 | +8.99 | +22.83 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- March 31st, 2025
- Incorporated
- June 13th, 2006
- Public Since
- July 21st, 2025
- No. of Employees
- 2,062
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 561,610,051
- Address
- No 49 F1 & F2 CANARA BANK ROAD, BANGALORE, 560099
- Web
- https://www.anthembio.com/
- Phone
- +91 8066724000
- Contact
- Divya Prasad
- Auditors
- K.P. Rao & Co.
Similar to ANTHEM
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 19:16 UTC, shares in Anthem BioSciences are trading at IN₹738.40. This share price information is delayed by 15 minutes.
Shares in Anthem BioSciences last closed at IN₹738.40 and the price had moved by over the past 365 days. In terms of relative price strength the Anthem BioSciences share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAnthem BioSciences does not currently pay a dividend.
Anthem BioSciences does not currently pay a dividend.
Anthem BioSciences does not currently pay a dividend.
To buy shares in Anthem BioSciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹738.40, shares in Anthem BioSciences had a market capitalisation of IN₹414.69bn.
Here are the trading details for Anthem BioSciences:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ANTHEM
Based on an overall assessment of its quality, value and momentum Anthem BioSciences is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Anthem BioSciences. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹738.40, shares in Anthem BioSciences were trading -2.09% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Anthem BioSciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹738.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Anthem BioSciences' directors